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Abstract
Objective To describe a posterolateral fluoroscopy-guided
injection technique into the posterior subtalar joint and to
report patient outcomes 1 month post-injection.
Materials and methods Twenty-three consecutive adult
patients who underwent fluoroscopy-guided injection into
the posterior subtalar joint using a direct posterolateral
approach and who returned an outcomes-based postal
questionnaire after receiving this injection were included.
Numerical pain rating scale (NRS) data were collected prior
to injection. NRS and Patient’s Global Impression of
Change (PGIC) scales were completed 1 day, 1 week, and
1 month after injection. The proportion of patients who
improved was calculated for each time period. Baseline
NRS data were compared to each time point using the
Wilcoxon test to assess differences. Spearman’s correlation
coefficient was used to compare the 20 min NRS score with
all follow-up NRS scores. All available images were
reviewed for the presence of subtalar osteoarthritis (OA).
Patient charts were reviewed to identify characteristics of
patients referred for subtalar injections. Risk ratios were
calculated comparing presence of OA or other abnormali-
ties with improvement.
Results A posterolateral approach for fluoroscopy-guided
injections into the subtalar joint is described. There was a
significant reduction in the mean NRS score at all time
periods compared to baseline (p ≤ 0.004). One-third of
patients (7/21) reported clinically relevant improvement at
1 month.
Conclusions Fluoroscopy-guided puncture of the posterior
subtalar joint using a posterolateral approach is possible.
Clinically significant improvement is reported in 33% of
patients after 1 month.
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Introduction
Diagnostic or therapeutic injection procedures into the foot
region have been used for many years to help diagnose a
particular joint as a pain source or to provide treatment to a
painful articulation [1–6]. Studies have shown that injec-
tions performed using imaging guidance (fluoroscopy,
ultrasound, or CT) more accurately deliver the medications
to the desired target joint compared to injections using
palpation alone [1, 3–11].
The posterior subtalar joint is one of the most typically
injected foot articulations [10–15]. There are various
techniques described in the literature for injecting medica-
tion into this joint, including the anterolateral, poster-
omedial, lateral oblique, and posterolateral approaches
[10–13, 15]. Previously the anterolateral approach was
claimed to be the best for injecting the posterior subtalar
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joint [11, 16] as this approach appeared to be comparably
easy with less chance of contrast leakage or side effects.
However, in most of these approaches the joint space is
often difficult to visualize with fluoroscopy because of
superimposed structures. A recent study comparing the
anterolateral with a posterolateral subtalar injection
approach determined that the posterolateral approach
was much more accurate [16]. No imaging guidance was
used in that study and it was done on cadaveric feet. Thus
details about exact patient positioning and the ability to
visualize the subtalar joint are missing.
Although a commonly performed procedure, little has
been published about the effectiveness of anesthetic and
corticosteroid injections specifically into the posterior
subtalar articulation. Two prospective and one retrospective
outcomes studies performed on patients with the specific
diagnosis of juvenile chronic arthritis documented substan-
tial clinical improvement in up to 44% of these patients.
Sample sizes were rather small, consisting of 6, 10, and 38
subtalar joint injections, respectively [10, 12, 13]. A larger,
prospective outcomes study (done recently from this
orthopedic university hospital) demonstrated that 64% of
the 118 adult patients who received subtalar injections
reported at least a 50% reduction in their pain 20–30 min
after injection [14]. These patients had a wide variety of
clinical conditions ranging from trauma to degenerative or
inflammatory arthropathies, and the injection technique
used to target the subtalar joint differed from those reported
in the literature to date. The procedure used at this facility is
a direct posterolateral approach. With the direct posterolateral
approach, the joint space is easy to identify without super-
imposed anatomical structures. To our knowledge, the
technical details of this injection approach have not been
published previously, although the recent study by Kraus et al.
[16] on cadaveric specimens superficially appears quite
similar. The purpose of this paper is to describe this
technique and to report the patient outcomes up to 1 month
post-injection from 23 consecutive patients who returned
postal questionnaires.
Materials and methods
Fluoroscopy-guided direct posterolateral subtalar injection
procedure
Patient and x-ray tube positioning
A fully digital C-arm fluoroscopy system was used
(Ultimax-i, Toshiba Medical Systems, Tokyo, Japan). The
patient was placed in a lateral position on the fluoroscopy
table, similar to the recovery position of an emergency
patient, with the involved foot on the upside and the leg
fully extended. The bottom leg was flexed 90° at the knee
and the foot was placed in the popliteal fossa of the upper
leg. If necessary, the foot to be injected was further
stabilized with pads. The patient had to feel comfortable
enough to rest for at least 5 min without moving the
involved foot.
The X-ray beam was then adjusted to the orientation of
the posterior subtalar joint space. The posterior subtalar
joint was centered in the image and the X-ray tube
positioned for a lateral-medial view of the foot. The X-ray
tube position was then fine-tuned until the very posterior
joint space was visible as a line between the talar and
calcaneal cortex (Fig. 1). The skin at the posterior contour
of the distal ankle had to be included in the image (Fig. 1a)
because the contour of the Achilles tendon served as a
landmark for the correct entry site of the needle into
the skin.
Normally, the X-ray beam was tilted approximately 15°
in a caudal-cranial direction and slightly posterior-
anteriorly. When performed by an experienced technician,
it was possible to achieve this by only using fluoroscopy
once for a quick control image.
Joint puncture
Intraarticular drugs were injected in a standardized fashion
by fellowship-trained musculoskeletal radiologists with at
least 3 years of experience in musculoskeletal injections.
All injections were done under sterile conditions, involving
disinfecting the overlying skin three times, and the use of
sterile gloves and a mask by the radiologist doing the
procedure. A fenestrated sterile surgical drape was placed
on the ankle.
A 23 G needle 0.60×60 mm (B. Braun, Melsungen,
Germany) was used. The needle was placed on the skin
over the joint space and adjusted to the direction of the joint
space under fluoroscopic control. The intersection of a
projected line through the needle and the lateral contour of
the Achilles tendon was identified as the puncture site on
the skin (Fig. 2). The skin was punctured and the needle
was advanced into the posterior subtalar joint under
fluoroscopic control aiming at the posterior-most part of
the joint (Fig. 1). The needle was directed from posterior to
anterior. Additionally, care was taken to point the needle
from lateral to central.
The correct position of the tip of the needle was verified
by the linear dispersion of an initially injected small amount
of contrast media (0.5–1 ml of iopamidol 200 mg/mL,
Iopamiro 200, Bracco, Milan, Italy) within the posterior
subtalar joint (Fig. 3). The various contrast filling patterns
are found in Fig. 3.
If the referring physician asked for a therapeutic
infiltration, 2 ml of crystal suspension of triamcinolone
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(Kenacort; triamcinolone acetate 40 mg/ml; Dermapharm,
Huenenberg, Switzerland) was injected. Additionally,
different volumes of mepivacaine hydrochloride 2%
(Scandicain 2%; AstraZeneca, Södertälje, Sweden) were
injected—normally about 2 ml—until the patient felt a
sensation of fullness or resistance was determined by the
radiologist. If the referring physician asked for a purely
diagnostic infiltration, only mepivacaine hydrochloride
2% was injected.
Local anesthetics for the skin and joint capsule were not
used on a standardized basis by all radiologists. Local
anesthetic administration produces a transient burning pain
when injected in the skin, joint capsule, or any other tissue
with sensitive nerve fibers. Performing the puncture
without local anesthetics produces the same needle prick,
but no additional pain caused by the local anesthetic.
Outcomes
Starting in January 2010, all patients receiving imaging-
guided musculoskeletal injections at this institution were
asked to participate in quality assurance studies on the
effectiveness of these injections and were instructed in the
study protocol. Ethics approval was received from the
institutional ethics committee, and written informed consent
was obtained from all patients. This paper focused only on
the subtalar joint and is limited to the 23 patients receiving
therapeutic injections.
The questionnaire used for this investigation included a
numerical rating scale (NRS) for pain and the Patient’s
Global Impression of Change Scale (PGIC) [17]. The same
Fig. 2 Photograph of the lateral aspect of the ankle joint with
superimposed schematic bony structures of a 25-year-old male
volunteer. After optimal placement of the ankle and X-ray tube
positioning, the posterior subtalar joint is nicely seen (arrowheads).
The needle tip position is marked with a red arrow. The intersection of
a projected line (red line) through the posterior subtalar joint
(arrowheads) and the lateral contour of the Achilles tendon (asterisk)
is identified as the correct puncture site on the skin (white dot marked
with the white arrow). To identify the puncture site, the needle is
placed on the skin over the joint space and adjusted to the direction of
the joint space under fluoroscopic control
Fig. 1 Lateral fluoroscopy images of a phantom of the ankle joint
consisting of the skeleton of a human distal lower leg and ankle joint
embedded in acrylic glass. a The X-ray tube was adjusted to the joint
space of the posterior subtalar joint (arrows). Especially in the very
posterior part, the joint space has to be visible. The skin (acrylic glass
contour of the phantom; large arrowheads) is needed on the image in
order to identify the correct puncture site. b To identify the optimal
puncture site of the skin, the needle (small arrowheads) is held over
the joint space under fluoroscopy. The puncture site is found visually
where a line along the needle crosses the lateral contour of the
Achilles tendon (see also Fig. 2). The skin is punctured, and the
needle is advanced with one quick movement into the joint under
fluoroscopic control
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data were acquired 1 day, 1 week, and 1 month after the
injection procedure. The NRS for pain is an 11-point scale
ranging from 0 (no pain) to 10 (unbearable pain). The
PGIC scale is a 7-point verbal scale assessing multiple
aspects of the patient’s quality of life and response to
treatment. The response options include “much worse,”
“worse,” “slightly worse,” “no change,” “slightly better,”
“better,” and “much better.” An addressed, stamped
envelope was also given to each patient with instructions
to return the completed questionnaire (for all time points)
to the radiology department after 1 month. No postal or
telephone reminders were given to patients who failed to
return their questionnaires. As part of the standard
procedures, all patients at this institution routinely complete
a pre-injection NRS score as well as a 20–30 min post-
injection NRS score whether or not they agreed to
participate in the study.
One of the radiologists with 5 years of experience in
musculoskeletal radiology who was also involved in the
injections retrospectively reviewed all available diagnostic
images that included the subtalar region after an interval of
at least 2 months after the last injection. He was not aware
of the clinical outcome. The presence or absence of
osteoarthritis (yes/no) of the subtalar joint was recorded.
Osteoarthritis of the subtalar joint was defined as the
presence of osteophytes, subchondral osteosclerosis, and
joint space narrowing. In addition, the presence of other
potentially pain-generating abnormalities at the hindfoot
such as bone marrow edema, Achilles tendinitis or para-
tenonitis, tendinitis or tenosynovitis of the tendons of the
flexor muscles or peroneal muscles, and tarsal coalition was
recorded. One of the referring clinicians retrospectively
reviewed all patient files in an attempt to identify specific
or common characteristics of patients referred for subtalar
injections.
Statistical analysis
Patients responding better or much better on the PGIC were
categorized as “improved” and the other patients as either
“no change” or “worse.” The response of “slightly better”
was not considered “improved.” The proportion (%) of
patients improved or worse after the subtalar injection was
calculated for each time period. Data were entered into
the SPSS program (version 17.0, SPSS, Chicago, IL).
Spearman’s correlation coefficients for non-parametric
data were calculated comparing the predictive value of
the 20-min post-injection NRS score to each of the later
follow-up time periods. The baseline NRS score was also
compared to each of the follow-up time points using the
Wilcoxon test for matched pairs to assess for differences.
P<0.05 was considered significant.
Fig. 3 Contrast media
dispersion in the posterior
subtalar joint space. Different
patterns of contrast media
dispersion are shown. The
needle (white arrowheads) is
placed in the joint space and the
contrast media shows a linear
dispersion pattern (black
arrows). a A 45-year-old
woman. Abundant contrast
media injection. b A 55-year-old
man. Injection of only a small
amount of contrast media. c A
37-year-old man. Injection in the
presence of an accessory ossicle
(Os trigonum). The contrast
media fills the posterior joint
recess (white arrow). d A
48-year-old man. Contrast
media dispersion can be
confusing when the posterior
joint recess is filled. Careful
injection of more contrast
media, however, confirms
linear dispersion in the joint
space (black arrows)
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Risk ratios with 95% confidence intervals (CI) were also
calculated comparing (1) the presence of OA of the subtalar
joint with patient improvement; and (2) the presence of other
potentially pain-generating abnormalities on the images
(other than at the subtalar joint) with patient improvement.
Results
A fluoroscopically guided subtalar joint injection with a
posterolateral approach has been introduced. All patients
received both an anaesthetic as well as corticosteroids. Of
the 23 patients included in this study, 11 were male (48%)
and 12 were female. The mean patient age was 52.0 years
(SD 20.0) with an age range of 20–78 years. Two patients
failed to answer the NRS and PGIC at 1 month, leaving 21
patients with data for that time point.
There was a statistically significant reduction in the
mean NRS score at all time points compared to the
baseline, pre-injection score (Table 1). This was most
pronounced at the 20 min post-injection time period and
least significant after 1 month. The correlation between the
pain reduction at 20 min after injection to the 1 day, 1 week,
and 1 month time points was only statistically significant
1 day after injection. The r values were 0.46 (p=0.03) at
1 day, 0.35 (p=0.115) at 1 week, and 0.40 (p=0.08) at
1 month. The results from the patient’s global impression of
change (PGIC) scale (Table 1) demonstrated that 43% (10/
23) of patients reported being “better” or “much better”
(clinically significantly improved) 1 day after injection, but
26% (6/23) reported being “worse” (31% unchanged).
Similarly, at 1 week post-injection 43% (10/23) of patients
were “better” or “much better” while 14% (3/23) reported
being “worse” (43% unchanged). At 1 month after injection
33% (7/21) of patients stated that they were “better” or
“much better,” 17% (3/21) claimed to be worse, and 50%
were unchanged compared to before the injection.
The risk ratio comparing patients with osteoarthritis of
the subtalar joint and clinically significant improvement
after injection was 2.8 (95% CI 0.25–30.91). The risk ratio
comparing patients with other potential pain sources outside
the subtalar joint, as viewed on imaging, with lack of
clinically significant improvement after injection was 3.25
(95% CI 1.4–7.3).
Discussion
Joint injections need to be safe, associated with as little
radiation exposure as possible, fast, and easy to learn. They
should also require as little technical and staff effort as
possible. The authors believe that fluoroscopically guided
injections are superior in this regard when compared to
CT guidance. CT may be useful for difficult injections.
Ultrasonographic guidance does not cause radiation
exposure, but identification of the individual joints and
following the course of the injection are more difficult
than with fluoroscopy.
Some radiologists do diagnostic and therapeutic blocks
in the subtalar joint by simply injecting the ankle joint from
an anterior approach, as there is very frequently communi-
cation between the two joints. Because this communication
may not be present in a specific patient, direct injection is
clearly superior.
Beaudet and Dixon [12] described a lateral approach to
puncture the subtalar joint with the patient in a prone
position using a straight lateral approach whereas our
technique uses the most posterior approach possible
without lacerating the Achilles tendon. This technique is
based on measurements at the lateral aspect of the ankle in
order to determine the correct puncture site. Using this
technique, routine radiographs of the foot in lateral and
medial oblique projections are performed, and the location
where the needle should be placed is generally not as
clearly seen as in our proposed technique using fluoroscopy
and with the patient in a lateral position. In the posterolateral
injection approach the posterior subtalar joint space is
projected freely, allowing fast puncture and easy correction
of the puncture direction during the forward movement of
the needle. A previous study reported that the posteromedial
approach to the subtalar joint was deemed more difficult
compared to the other approaches [16]. Furthermore, 4
patients out of 24 (17%) injected from posteromedially had
unwanted anesthesia of the toes. This may have been
caused by drug leakage out of the joint and drug action at
the medial or lateral plantar nerves, which run close to the
puncture site.
In this manuscript a subtalar injection technique is
described using a posterolateral approach to the posterior
subtalar articulation. The authors believe that this technique
Table 1 Patient outcomes at various time points after imaging-guided
subtalar injection
NRS PGIC
Mean (SD) p value
Pre-injection 6.5 (2.0)
20 min post-injection 2.7 (2.8) 0.0001*
1 Day 4.4 (3.0) 0.004* 43% better, 26% worse
1 Week 4.2 (3.1) 0.001* 43% better, 14% worse
1 Month 4.7 (3.1) 0.004* 33% better, 17% worse
NRS Numerical pain rating scale, PGIC Patient’s Global Impression of
Change scale, SD standard deviation
*p<0.05 compared to baseline data
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is fast, easy to learn, and safe. Because of the posterolateral
approach, no major nerves or vessels are at risk of being
incidentally punctured. Kraus et al. [16] reported that the
posterolateral injection approach is also more accurate than
the anterolateral approach even when imaging guidance is
not used.
This pilot study of short and medium term outcomes
shows that there was a significant reduction in the mean
NRS scores at all follow-up time points, particularly at 20–
30 min after injection, but that only approximately one-
third of patients reported clinically relevant improvement at
1 month on the PGIC scale. Clinically relevant improve-
ment incorporates a variety of factors beyond simply the
measurement of pain. Function and the patient’s quality of
life are also included and thus this PGIC result is a more
useful determinant of overall improvement. Additionally, a
relevant number of patients were actually worse 1 day after
injection. Interestingly, the amount of pain reduction
reported 20–30 min after injection does not consistently
predict the outcome at the later time points. These findings
could possibly be explained by the pharmacodynamics of
the injected drugs. The manufacturer’s information states
that mepivacain has an elimination half-life of about 2 h.
Triamcinolone, on the other hand, takes about 3–7 days to
become effective and has a mean clinical effect of
approximately 3 weeks. Therefore, at 1 day post injection,
the anesthetic is no longer present and the corticosteroid has
not yet started to be effective. This could explain the fact
that a significant number of patients complain of being
worse 1 day post-injection. Additionally, after a period of
24 days the triamcinolone is no longer detectable in the
tissues (product insert, section concerning pharmacoki-
netics and elimination; Kenacort, Dermapharm). This
may explain why fewer patients report being clinically
significantly improved at 1 month compared to 1 week
after injection.
Comparing these results with the few small studies on
injections into the subtalar joint published previously is
encouraging however. The best outcome reported before
this current study was that up to 44% of children suffering
from juvenile chronic arthritis (JCA) reported substantial
improvement [13] over a long follow-up period. JCA is an
inflammatory arthropathy, and thus the injection of a
corticosteroid would be expected to reduce their symptoms.
The patients in our study suffered from a variety of
conditions including osteoarthritis, but inflammatory con-
ditions were not common. This is likely the reason why the
most pronounced pain reduction observed in this current
study happened 20 min after injection as a result of the
anaesthetic, but by 1 day post-injection was substantially
less as the anaesthetic affect was no longer present.
The review of the diagnostic images as well as the
patient charts confirmed that patients with osteoarthritis
located at the subtalar joint were more likely to have a
favorable response to the injection (i.e., 2.8 times more
likely to improve), when compared to patients with
potentially pain-generating pathologies at sites other than
the subtalar joint. However, with the small numbers of
subjects and the very wide confidence interval as a result,
these findings should not be over-interpreted at this time.
Our results support those reported previously by Mitchel at
al. [6] who found that the degree of pain relief after subtalar
injection correlated with the severity of degenerative
changes found in this joint. Although all of these injections
included a corticosteroid, some were performed for a
diagnostic rather than a therapeutic purpose.
There are limitations to this study other than the small
sample size. Only patients who returned their postal
questionnaire were included in this pilot study. A review
of the imaging database revealed that only 40% of patients
with subtalar joint injections complied with the request.
Patients who continue to experience pain and disability may
be more likely to return these questionnaires compared to
patients who feel substantially better. This is only a
hypothesis however and requires follow-up studies. The
cost implications of hiring research assistants to telephone
patients who did not return their postal questionnaires
precluded this being part of the current study. Even if only
43% of patients are clinically significantly improved at
1 day and 1 week post-injection with 33% improved at
1 month, this is important information for referring
clinicians. For clinicians, it is important to know that
patients with osteoarthritis of the posterior subtalar joint
may have a better response to these injections than patients
with normal imaging findings.
In conclusion, fluoroscopy-guided posterolateral punc-
ture of the posterior subtalar joint is not only possible, but
relatively easy to use and probably preferable to an
anterolateral approach. Clinically significant improvement
is reported in 33% of patients after 1 month.
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